Business
XPC: EU approval paves way for commercial launch; rights issue boosts capital for growth
XPC: EU approval paves way for commercial launch; rights issue boosts capital for growth
About this update from Xp Chemistries Ab
EU approval for high-purity capsaicin as a feed additive is imminent, enabling a shift from regulatory focus to commercial launch. Financials show stable revenue, ongoing losses, and a strengthened balance sheet after a fully subscribed rights issue raising 22.9 MSEK.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.